“Alarming” Number of US FDA Recalls Attributed To Equipment Breakdowns
Sanofi Describes Its Proactive Approach To Maintenance
Executive Summary
Agency urges pharmaceutical industry to be proactive on equipment monitoring. Sanofi efforts include an interdisciplinary approach to equipment inspections.
You may also be interested in...
FDA Warns Consumers Not To Use Sterile Drugs Made By Pacifico National After Firm Refuses Recall Requests
After Melbourne, Florida, outsourcer resisted entreaties to recall sterile drugs over contamination and eye infections, the FDA warned consumers not to use sterile drugs compounded by the firm, Pacifico National, doing business as AmEx Pharmacy.
Aurobindo Faulted In US FDA Warning Letter For Poor Root Cause Investigations
Aurobindo failed to properly investigate problems with carcinogenic impurities in active pharmaceutical ingredients, warning letter says.
Program Participants Urge The FDA To Adopt Some Pharmaceutical Quality Metrics And Avoid Others
Site-based metrics praised; lot acceptance rates, invalidated OOS rates discouraged. Agency official admits some proposed metrics were “not the best.”